198 related articles for article (PubMed ID: 17078596)
21. Influence of nonsteroidal anti-inflammatory drugs on the antiplatelet effects of aspirin in rats.
Akagi Y; Nio Y; Shimada S; Aoyama T
Biol Pharm Bull; 2011; 34(2):233-7. PubMed ID: 21415533
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects.
Capone ML; Sciulli MG; Tacconelli S; Grana M; Ricciotti E; Renda G; Di Gregorio P; Merciaro G; Patrignani P
J Am Coll Cardiol; 2005 Apr; 45(8):1295-301. PubMed ID: 15837265
[TBL] [Abstract][Full Text] [Related]
23. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
Rahme E; Nedjar H; Bizzi A; Morin S
Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
[TBL] [Abstract][Full Text] [Related]
24. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
25. [A novel class of anti-inflammatory and analgesic drugs--NO-donating NSAIDs].
Zhang YH; Ji H; Peng SX
Yao Xue Xue Bao; 2007 Apr; 42(4):352-7. PubMed ID: 17633199
[TBL] [Abstract][Full Text] [Related]
26. Terms and conditions: semantic complexity and aspirin resistance.
Hennekens CH; Schror K; Weisman S; FitzGerald GA
Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
[No Abstract] [Full Text] [Related]
27. [Cardiovascular risk of non-steroidal anti-inflammatory drugs].
Prozzi GR; Cañás M; Urtasun MA; Buschiazzo HO; Dorati CM; Mordujovich-Buschiazzo P
Medicina (B Aires); 2018; 78(5):349-355. PubMed ID: 30285927
[TBL] [Abstract][Full Text] [Related]
28. Possible mechanisms of drug-induced aspirin and clopidogrel resistance.
Schroeder WS; Ghobrial L; Gandhi PJ
J Thromb Thrombolysis; 2006 Oct; 22(2):139-50. PubMed ID: 17008981
[TBL] [Abstract][Full Text] [Related]
29. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation.
Galliard-Grigioni KS; Reinhart WH
Eur J Pharmacol; 2009 May; 609(1-3):96-9. PubMed ID: 19272375
[TBL] [Abstract][Full Text] [Related]
30. Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin.
Yokoyama H; Ito N; Soeda S; Ozaki M; Suzuki Y; Watanabe M; Kashiwakura E; Kawada T; Ikeda N; Tokuoka K; Kitagawa Y; Yamada Y
J Clin Pharm Ther; 2013 Feb; 38(1):12-5. PubMed ID: 22882748
[TBL] [Abstract][Full Text] [Related]
31. Impact of nonsteroidal antiinflammatory drugs on the cardioprotective effects of aspirin.
Corman SL; Fedutes BA; Ansani NT
Ann Pharmacother; 2005 Jun; 39(6):1073-9. PubMed ID: 15870140
[TBL] [Abstract][Full Text] [Related]
32. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers.
Gladding PA; Webster MW; Farrell HB; Zeng IS; Park R; Ruijne N
Am J Cardiol; 2008 Apr; 101(7):1060-3. PubMed ID: 18359332
[TBL] [Abstract][Full Text] [Related]
33. [A 100 years of aspirin: a drug with a future?].
Sánchez García P
An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
[No Abstract] [Full Text] [Related]
34. [Investigation of the combination of aspirin with non-steroidal anti-inflammatory drugs].
Ito N; Yokoyama H; Soeda S; Suzuki Y; Ikeda N; Tokuoka K; Watanabe M; Kitagawa Y; Yamada Y
Yakugaku Zasshi; 2011; 131(7):1073-7. PubMed ID: 21720137
[TBL] [Abstract][Full Text] [Related]
35. Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets.
Saxena A; Balaramnavar VM; Hohlfeld T; Saxena AK
Eur J Pharmacol; 2013 Dec; 721(1-3):215-24. PubMed ID: 24075938
[TBL] [Abstract][Full Text] [Related]
36. Prediction of time-dependent interaction of aspirin with ibuprofen using a pharmacokinetic/pharmacodynamic model.
Awa K; Satoh H; Hori S; Sawada Y
J Clin Pharm Ther; 2012 Aug; 37(4):469-74. PubMed ID: 22122406
[TBL] [Abstract][Full Text] [Related]
37. Selective COX-2 Inhibitors, NSAIDs, aspirin, and myocardial infarction.
Dalen JE
Arch Intern Med; 2002 May; 162(10):1091-2. PubMed ID: 12020175
[No Abstract] [Full Text] [Related]
38. Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences.
Anzellotti P; Capone ML; Jeyam A; Tacconelli S; Bruno A; Tontodonati P; Di Francesco L; Grossi L; Renda G; Merciaro G; Di Gregorio P; Price TS; Garcia Rodriguez LA; Patrignani P
Arthritis Rheum; 2011 Mar; 63(3):850-9. PubMed ID: 21360514
[TBL] [Abstract][Full Text] [Related]
39. Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy.
Moro MG; Sanchez PK; Gevert MV; Baller EM; Tostes AF; Lupepsa AC; Baglie S; Franco GC
Braz Oral Res; 2016 Nov; 30(1):e127. PubMed ID: 27901208
[TBL] [Abstract][Full Text] [Related]
40. Recent FDA warning of the concomitant use of aspirin and ibuprofen and the effects on platelet aggregation.
Ellison J; Dager W
Prev Cardiol; 2007; 10(2):61-3. PubMed ID: 17392619
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
